Lifecore Biomedical, Inc. De (LFCR) EV to FCF (2010 - 2025)

Lifecore Biomedical has reported EV to FCF for 16 years, with the latest figure at 239.35 in Q2 2025.

• On a quarterly basis, EV to FCF fell 979.87% year-over-year to 239.35 in Q2 2025; TTM through May 2025 was 13.46, a 49.46% decrease from a year earlier, with the FY2025 full-year figure at 17.66, down 96.15% from the prior year.
• EV to FCF was 239.35 for Q2 2025 at Lifecore Biomedical, down from 47.52 in the prior quarter.
• The five-year high for EV to FCF was 27.2 in Q2 2024, with the low at 239.35 in Q2 2025.
• Average EV to FCF over 5 years is 43.54, with a median of 31.04 recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: EV to FCF jumped 215.79% in 2024, then slumped 979.87% in 2025.
• Over 5 years, EV to FCF stood at 24.92 in 2021, then plunged by 60.29% to 39.94 in 2022, then tumbled by 92.66% to 76.94 in 2023, then jumped by 60.48% to 30.4 in 2024, then sank by 687.22% to 239.35 in 2025.
• The last three EV to FCF figures came in at 239.35 (Q2 2025), 47.52 (Q1 2025), and 30.4 (Q4 2024), per Business Quant data.